Mandar Muzumdar MD
Gastrointestinal Cancer
Associate Professor of Genetics and of Internal Medicine (Medical Oncology, Cancer Biology Institute, Yale University School of Medicine Scientific Director, Center for Gastrointestinal Cancers, Smilow Cancer Hospital and Yale Cancer Center
Join to View Full Profile
840 W Campus DrAdvanced Biosciences Center, 3rd FloorWest Haven, CT 06516
Dr. Muzumdar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Koch Institute for Integrative Cancer ResearchPost-Doctoral Fellowship, 2011 - 2017
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2010 - 2014- Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 2008 - 2010
Stanford University School of MedicineClass of 2008
Certifications & Licensure
CT State Medical License 2017 - 2025
MA State Medical License 2011 - 2017
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Damon Runyon-Rachleff Innovation Award Damon Runyon Cancer Research Foundation, 2021
- Early Career Award Cancer Research journal, 2019
- New Innovator Award National Institutes of Health, 2019
- Join now to see all
Publications & Presentations
PubMed
- Keep It Moving: Physical Activity in the Prevention of Obesity-Driven Pancreatic Cancer.Akin Sogunro, Mandar D Muzumdar
Cancer Research. 2024-09-16 - 2 citationsTracing the evolution of single-cell cancer 3D genomes: an atlas for cancer gene discovery.Miao Liu, Shengyan Jin, Sherry S Agabiti, Tyler B Jensen, Tianqi Yang
Biorxiv. 2024-09-09 - 6 citationsPerioperative Modified FOLFIRINOX for Resectable Pancreatic Cancer: A Nonrandomized Controlled Trial.Michael Cecchini, Ronald R Salem, Marie Robert, Suzanne Czerniak, Ondrej Blaha
JAMA Oncology. 2024-08-01
Press Mentions
A Pressing Need for New Ideas for Pancreatic CancerFebruary 25th, 2021
Study Points to Obesity as Driver of Pancreatic CancerApril 16th, 2020
Grant Support
- K08National Cancer Institute2016–2021
- Research Investigator GrantLustgarten Foundation2015–2017
- KL2/CMeRITHarvard Medical School Catalyst and NIH2014–2016
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
